Outcomes of patients treated with capecitabine and temozolamide for advanced pancreatic neuroendocrine tumors (PNETs) and non-PNETs

BACKGROUND: Retrospective studies have demonstrated high response rates among patients with advanced pancreatic neuroendocrine tumors (PNETs) treated with capecitabine and temozolamide (CapTem), while responses are infrequently seen among non-PNETs. The objective of the study was to describe progres...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Peixoto, Renata D’Alpino, Noonan, Krista L., Pavlovich, Peter, Kennecke, Hagen F., Lim, Howard J.
Format: Artigo
Idioma:Inglês
Publicat: Pioneer Bioscience Publishing Company 2014
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4110496/
https://ncbi.nlm.nih.gov/pubmed/25083296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2078-6891.2014.019
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars